^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Thymoma

Related cancers:
13h
CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression. (PubMed, Autophagy)
The oncogenic potential of CKAP4 in HCC was demonstrated using various animal models. Clinical sample analyses suggested that CKAP4 is a potential biomarker for HCC prognosis and diagnosis.Abbreviation: AKT: thymoma viral proto-oncogene; aa: amino acid; bp: base pair; CHX: cycloheximide; co-IP: co-Immunoprecipitation; CQ: chloroquine; CKAP4: cytoskeleton-associated protein 4; DKK1: dickkopf WNT signaling pathway inhibitor 1; DUBs: deubiquitinating enzymes; EBSS: Earle's balanced salt solution; EGFP: enhanced green fluorescent protein; ER: endoplasmic reticulum; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GFP: green fluorescent protein; HCC: hepatocellular carcinoma; HFD: high-fat diet; HiTV: hyperdynamic tail vein injection; IF: immunofluorescence; IHC: immunohistochemistry; IP-MS: immunoprecipitation-mass spectrometry; LIR: LC3-interacting region; mAbs: monoclonal antibodies; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; mCherry: monomeric cherry; oe: overexpression; PDX: patient-derived tumor xenograft; reticulophagy: endoplasmic reticulum selective autophagy; RETREG1: reticulophagy regulator 1; RHD: reticulon-homology domain; Tg: thapsigargin; Tm: tunicamycin; TRIM21: tripartite motif-containing 21; UB: ubiquitin; WT: wild-type.
Journal
|
DKK1 (dickkopf WNT signaling pathway inhibitor 1) • GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) • MAP1LC3B (Microtubule Associated Protein 1 Light Chain 3 Beta) • CKAP4 (Cytoskeleton Associated Protein 4) • TRIM21 (Tripartite Motif Containing 21)
|
chloroquine phosphate
16h
A woman with multifocal lipodystrophy in unilateral trunk and extremities. (PubMed, Neuro Endocrinol Lett)
In this report, we describe a rare case of localized lipodystrophy characterized normal development and partial multifocal fat atrophy. This case aims to enhance clinicians' understanding of the clinical manifestation of this uncommon disease.
Journal
|
CAV1 (Caveolin 1) • LMNA (Lamin A/C) • AKT2 (V-akt murine thymoma viral oncogene homolog 2) • PPARG (Peroxisome Proliferator Activated Receptor Gamma) • PSMB8 (Proteasome 20S Subunit Beta 8)
7d
New P2 trial
|
cisplatin • albumin-bound paclitaxel
15d
Surgical treatment of thymic epithelial tumor and myasthenia gravis. (PubMed, Front Surg)
Treatment includes cholinesterase inhibitors and immunotherapy agents, with extended thymectomy serving as an effective surgical option for drug-resistant cases. Minimally invasive approaches (video-assisted thoracoscopic surgery or robot-assisted thoracoscopic surgery) have demonstrated comparable oncological outcomes to sternotomy, highlighting their effectiveness and reliability.
Review • Journal
|
LRP4 (LDL Receptor Related Protein 4)
26d
Ectopic Thymoma in the Thorax With Associated Myasthenia Gravis. (PubMed, Cureus)
Paraneoplastic syndromes are rarely reported in association with ectopic thymoma, making this case unusual. We discuss the nuances of diagnosis, classification, and staging of this rare case, as well as the patient's subsequent management by cardiothoracic surgery and neurology specialists.
Journal
|
TTN (Titin)
30d
The impact of immune markers on thymectomy prognosis in thymoma-myasthenia gravis. (PubMed, J Thorac Dis)
Complement C3 level is a crucial predictor for long-term remission in thymoma-associated MG post-thymectomy. Patients with lower C3 levels are more likely to experience MG symptom progression post-surgery compared to those with normal levels, indicating its potential as a key prognostic marker.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • CRP (C-reactive protein)
1m
miRNAs in the diagnosis and therapy of cardiac and mediastinal tumors: a new dawn for cardio-oncology? (PubMed, Future Cardiol)
MiRNAs are crucial for cardiac development through the expression of cardiac transcription factors (miR-335-5p), hinder the cell cycle by modulating the activity of transcription factors (miR-126-3p, miR-320a), modulate the production of inflammatory factors such as interleukins (miR-217), and interfere with cell proliferation or apoptosis (miR-218, miR-634 and miR-122). Current and future research on miRNAs is essential, as a deep understanding could lead to a revolution in the field of diagnostics and prevention of neoplastic diseases.
Review • Journal
|
MIR126 (MicroRNA 126) • MIR320A (MicroRNA 320a) • MIR335 (MicroRNA 335) • MIR122 (MicroRNA 122) • MIR217 (MicroRNA 217) • MIR218 (MicroRNA 218)
1m
DNA methylation analysis of multiple genes in thymic epithelial tumors. (PubMed, Epigenomics)
No difference in the methylation levels of the investigated genes was seen among TM stages and subtypes. No changes in blood methylation levels of the investigated genes were seen among TET subtypes. The present study confirms GHSR, ELF3, IL1RN and RAG1 as TET epigenetic biomarkers.
Journal • Epigenetic controller
|
ELF3 (E74 Like ETS Transcription Factor 3) • IL1RN (Interleukin 1 receptor antagonist) • RAG1 (Recombination Activating 1)
1m
Rare atypical type a thymoma: a case report and literature review. (PubMed, Diagn Pathol)
We report a case of atypical type A thymoma and review the literature to enhance our understanding of and provide accumulated pathological data on this rare disease.
Review • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD20 (Membrane Spanning 4-Domains A1) • CD5 (CD5 Molecule) • KRT19 (Keratin 19) • TP63 (Tumor protein 63)
1m
Pancancer analysis of the interactions between CTNNB1 and infiltrating immune cell populations. (PubMed, Medicine (Baltimore))
Additionally, pathway enrichment suggested that NUMB is involved in the Wnt pathway. This study highlights the predictive role of CTNNB1 across cancers, suggesting that CTNNB1 might serve as a potential biomarker for the diagnosis and prognosis evaluation of various malignant tumors.
Journal • Pan tumor • Immune cell
|
CD8 (cluster of differentiation 8) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • RHOA (Ras homolog family member A)
|
CTNNB1 mutation • CTNNB1 expression
2ms
First reported case of thymoma-associated multiorgan autoimmunity induced by COVID-19. (PubMed, J Dermatol)
A 64-year-old female patient with a history of myasthenia gravis and thymoma treated with prednisolone (10 mg/day) and cyclosporine (150 mg/day) experienced erythema on her trunk after coronavirus disease 2019 (COVID-19) onset...During the disease course, candida fungemia and cytomegalovirus infection developed, resulting in the patient's death. The TAMA was considered to have been caused by the release of inflammatory cytokines, autoreactive T cell activation, and regulatory T cell dysfunction induced by COVID-19.
Journal
|
CD8 (cluster of differentiation 8)
|
CD8 positive
|
cyclosporine
2ms
Screening differentially expressed proteins to distinguish thymoma (B1 and B3) from thymic cysts based on tandem mass tag (TMT) technology. (PubMed, J Cardiothorac Surg)
GEPIA validated that LGALS3BP was significantly upregulated in thymoma patients. In conclusion, LGALS3BP might be an essential biomarker to identify thymoma from the thymic cyst.
Journal
|
LGALS3 (Galectin 3) • LGALS3BP (Lectin galactoside-binding soluble 3-binding protein) • TNN (Tenascin N)
2ms
B cell deficiency in thymoma tissues of Good's syndrome patients. (PubMed, Discov Oncol)
This is the first report of B cell deficiency in 5 thymoma tissues of GS patients.
Journal
|
CD20 (Membrane Spanning 4-Domains A1) • PAX5 (Paired Box 5) • SDC1 (Syndecan 1)
|
CD19 expression
2ms
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesicles. (PubMed, J Control Release)
This study presents a powerful and promising approach to overcoming the limitations of EV-based cancer vaccines, advancing the development of effective cancer immunotherapies. SUMMARY: Immunization with EVs that are co-associated with antigen and biotherapeutic cargo through a lyophilization-based technique elicits potent anti-cancer immunity.
Journal
|
IFNG (Interferon, gamma) • CD4 (CD4 Molecule)
2ms
Paclitaxel Drug-Drug Interactions in the Military Health System. (PubMed, Fed Pract)
The study provides a comprehensive overview of paclitaxel usage from 1996 through 2022 and highlights potential drug interactions that may affect treatment outcomes. While the impact of prescription drugs on paclitaxel discontinuation is uncertain, paclitaxel and antidepressants do not have significant drug-drug interactions.
Journal
|
CYP3A4 (Cytochrome P450, family 3, subfamily A, polypeptide 4)
|
paclitaxel
2ms
Biomarkers suitable for early detection of intrathoracic cancers in primary care: a systematic review. (PubMed, Cancer Epidemiol Biomarkers Prev)
However, few were evaluated in low-prevalence settings. Further evaluation is necessary before implementing these biomarkers for intrathoracic cancers in primary care.
Review • Journal
|
VEGFA (Vascular endothelial growth factor A) • MSLN (Mesothelin) • SPP1 (Secreted Phosphoprotein 1)
2ms
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities. (PubMed, Virchows Arch)
A small fraction of TTF-1-positive gastrointestinal adenocarcinomas represents a pitfall mimicking enteric-type pulmonary adenocarcinoma. Combined analysis of TTF-1 and Napsin-A improves the specificity of pulmonary adenocarcinoma diagnosis.
Journal
|
NKX2-1 (NK2 Homeobox 1) • NAPSA (Napsin A Aspartic Peptidase) • FABP1 (Fatty Acid Binding Protein 1)
3ms
Clinical • P1 data • Metastases
|
METTL3 (Methyltransferase Like 3)
|
nCounter® PanCancer IO 360™ Panel
|
STC-15
3ms
Identification of Potential Key Genes for the Comorbidity of Myasthenia Gravis With Thymoma by Integrated Bioinformatics Analysis and Machine Learning. (PubMed, Bioinform Biol Insights)
Finally, we found that five key genes and immune cell infiltrations presented varying degrees of correlation. Our study identified five key potential pathogenic genes that predisposed thymoma to the development of MG, which provided potential diagnostic biomarkers and promising therapeutic targets for MG patients with thymoma.
Journal • Machine learning
|
EGR1 (Early Growth Response 1) • MS4A6A (Membrane Spanning 4-Domains A6A)
3ms
DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma. (PubMed, J Pathol)
© 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland
Journal • Epigenetic controller
|
CDC42BPB (CDC42 Binding Protein Kinase Beta) • RBM24 (RNA Binding Motif Protein 24) • CASC2 (Cancer Susceptibility 2)
3ms
Deoxypodophyllotoxin Mediates Autophagy Death through Inhibition of GRP78 in Human Osteosarcoma. (PubMed, Curr Cancer Drug Targets)
Combination treatment with the GRP78 inhibitor DPT and pharmacological autophagy inhibitors will be a meaningful method of obviating osteosarcoma cells.
Journal • IO biomarker
|
mTOR (Mechanistic target of rapamycin kinase) • BAX (BCL2-associated X protein) • HSPA5 (Heat Shock Protein Family A (Hsp70) Member 5)
|
HSPA5 overexpression
|
sirolimus
3ms
Case report: Multi-antibody-positive myasthenia gravis concomitant myositis associated with thymoma. (PubMed, Front Immunol)
MG-concomitant IIM is often associated with thymoma. The immunopathology mechanism may be different from that of pure MG or IIM, which needs further research.
Journal
|
TTN (Titin)
3ms
Development and Validation of a Multi-Omics Nomogram Based on Transfer Learning to Predict Postoperative Efficacy of Thymoma Patients with Myasthenia Gravis (ChiCTR2400087232)
P=N/A, N=0, Completed, Xiangya Hospital, Central South University, Changsha, Hunan 410000, People’s Republic of China.; The Xiangya Hospital of Central South University
New trial
3ms
Cryptococcal inflammatory pseudotumour of the lung - a diagnostic pitfall (ECP 2024)
Based on histopathological and molecular results, the diagnosis of cryptococcal inflammatory pseudotumour was made. Only a few cases of cryptococcal inflammatory pseudotumours have been reported in the literature, mainly in HIV-positive patients. Our patient was not HIV-positive but ten months before the wedge resection, she had a type B2 thymoma treated with induction chemotherapy and consecutive resection (R1) as well as adjuvant chemotherapy.
ALK (Anaplastic lymphoma kinase) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD34 (CD34 molecule) • NKX2-1 (NK2 Homeobox 1) • SOX10 (SRY-Box 10) • STAT6 (Signal transducer and activator of transcription 6) • MYOD1 (Myogenic Differentiation 1)
|
FusionPlex® Pan Solid Tumor v2 panel
3ms
Depiction of the Genetic Alterations and Molecular Landscapes of Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis. (PubMed, Cancers (Basel))
The pooled estimated expression level of PD-L1 is 0.71 ([0.59-0.81]). This systematic review provides an overview of the gene alteration landscape and PD-L1 expression levels in TETs, discovers several potential confounding factors that may contribute to the high heterogeneity, and facilitates deeper investigations into the elucidation of the molecular landscape of TETs.
Retrospective data • Review • Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • TP53 (Tumor protein P53) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • TET2 (Tet Methylcytosine Dioxygenase 2)
|
PD-L1 expression • TP53 mutation
3ms
Goods syndrome in chronic active SARS-CoV-2 infection: a case report (PubMed, Zhonghua Jie He He Hu Xi Za Zhi)
The patient tested negative for SARS-CoV-2, but symptoms recurred soon after. Eventually, the diagnosis of Goods syndrome was made based on the presence of B-cell loss, decreased immunoglobulin levels, an inverted CD4+/CD8+ ratio on admission, and a previous history of thymoma.
Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
4ms
A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers. (PubMed, Front Immunol)
ADAM10 is also negatively associated with tumor immunosuppression and interrelated with the immune infiltration of tumors. Overall, the present study determined ADAM10 expression by AD, CD and m6 2A, and in AD or CD/ADAM10/LAG3 signaling in cancers, and suggested a potential method for immunotherapy of cancers by targeting ADAM10 using the small molecules AD, CD and m6 2A.
Journal • IO biomarker
|
LAG3 (Lymphocyte Activating 3) • HLA-B (Major Histocompatibility Complex, Class I, B) • TNFRSF4 (TNF Receptor Superfamily Member 4) • TNFRSF18 (TNF Receptor Superfamily Member 18) • CCL27 (C-C Motif Chemokine Ligand 27) • CXCR5 (C-X-C Motif Chemokine Receptor 5) • ADAM10 (ADAM Metallopeptidase Domain 10)
|
cordycepin (OVI-123)
4ms
Identification of Hub Genes and Analysis of their Regulatory miRNAs in Patients with Thymoma Associated Myasthenia Gravis Based on TCGA Database. (PubMed, Microrna)
Our study identified 5 hub genes (CTNNB1, EGFR, SOX2, ERBB2, and EGF) and their 5 regulatory miRNAs in TAMG, and the hub genes were correlated with multiple immune cell infiltrations and immune checkpoint-related markers. Our findings could help partially clarify the pathophysiology of TAMG, which could be new potential targets for subsequent clinical immunotherapy.
Journal • PD(L)-1 Biomarker • IO biomarker
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • SOX2
4ms
ACTN4 is associated with the malignant potential of thymic epithelial tumors through the β-catenin/Slug pathway. (PubMed, Cancer Sci)
A WB and immunohistochemistry staining comparison of primary and disseminated lesions of TETs using surgical specimens showed upregulated expression of ACTN4, β-catenin, and Slug proteins in disseminated lesions. In summary, our study suggests ACTN4 is associated with malignant potential characteristics such as invasion and dissemination in TETs via the β-catenin/Slug pathway.
Journal
|
SNAI2 (Snail Family Transcriptional Repressor 2) • ACTN4 (Actinin Alpha 4)
4ms
Genomic insights into molecular profiling of thymic carcinoma: a narrative review. (PubMed, Mediastinum)
Our findings revealed prognostic biomarkers such as TP53/CDKN2A and potential therapeutic targets such as KIT. Because thymic carcinoma is extremely rare, sharing molecular profiling data could provide valuable insights into the molecular mechanisms driving the development of these tumors.
Review • Journal • Tumor mutational burden • IO biomarker
|
TP53 (Tumor protein P53) • TMB (Tumor Mutational Burden) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • ASXL1 (ASXL Transcriptional Regulator 1) • BAP1 (BRCA1 Associated Protein 1) • TET2 (Tet Methylcytosine Dioxygenase 2) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • SETD2 (SET Domain Containing 2, Histone Lysine Methyltransferase)
4ms
Atypical Thymoma (WHO Type B3) with Prominent Microcystic and Mucoid Changes Mimicking Thymic Mucoepidermoid Carcinoma: A Clinicopathological and Immunohistochemical Study of Five Cases. (PubMed, Int J Surg Pathol)
This report highlights histological features in atypical thymoma that may be confused with other tumors, especially thymic mucoepidermoid carcinoma. Separation of these tumors may be important for patient management and prognosis.
Journal
|
TP63 (Tumor protein 63) • KRT5 (Keratin 5)
4ms
Weighted gene coexpression network analysis and machine learning for the determination of tfh cell and B cell infiltrating biomarkers in thymoma-associated myasthenia gravis. (PubMed, Heliyon)
Draggability analysis identified the therapeutic target genes PTGS2 and ALB, along with significant drugs including Firocoxib, Alclofenac, Pyridostigmine, and Stavudine...The interaction between numerous activated B cells and follicular helper T cells is closely associated with THYM-MG pathogenesis from a bioinformatics perspective. Hub genes (including SP6, SCUBE3, B3GNT7, and MAGEL2) may be downregulated in immune cells in THYM-MG and associated with progression.
Journal • Machine learning
|
CD4 (CD4 Molecule) • PTGS2 (Prostaglandin-Endoperoxide Synthase 2) • PACERR (PTGS2 Antisense NFKB1 Complex-Mediated Expression Regulator RNA)
4ms
Hematopoietic stem/progenitor cell transplantation recovers immune defects and prevents lymphomas in Atm-deficient mice. (PubMed, Exp Hematol Oncol)
We can conclude that wild-type enriched HSPCs transplantation into young Atm-deficient mice can ameliorate A-T hematopoietic phenotypes and prevent tumor of hematopoietic origin.
Preclinical • Journal
|
ATM (ATM serine/threonine kinase) • TRB (T Cell Receptor Beta Locus)
4ms
Clinical manifestations and immune markers of non-HIV-related CMV retinitis. (PubMed, BMC Infect Dis)
CMV retinitis is a rare disorder that can affect patients suffering any kind of immunodeficiency. It is associated with a high visual morbidity despite adequate treatment. CD4 + cell counts are usually higher than those in HIV patients, but B-cell dysfunction is common.
Retrospective data • Journal
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
5ms
Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns. (PubMed, Virchows Arch)
These results indicate that IHC of both YAP1(N) and YAP1(C) is recommended to obtain staining patterns almost unique to MT. The biological significance of YAP1 in high-grade TETs warrants further investigation.
Journal
|
YAP1 (Yes associated protein 1) • MAML2 (Mastermind Like Transcriptional Coactivator 2)
5ms
Metaplastic thymoma in the middle mediastinum: a rare case report and surgical treatment analysis of a 32-year-old female patient. (PubMed, AME Case Rep)
This report underscores the critical role of a multifaceted diagnostic approach, including histopathological, immunohistochemical, and genetic analyses, in the identification of MT. The detection of the YAP1::MAML2 gene fusion through FISH analysis provides a robust diagnostic marker, highlighting the necessity for clinical and pathological vigilance for this rare tumor.
Journal
|
YAP1 (Yes associated protein 1) • VIM (Vimentin) • MAML2 (Mastermind Like Transcriptional Coactivator 2)
5ms
Predictors and Prognostic Factors of Myasthenia Gravis Outcome (clinicaltrials.gov)
P=N/A, N=30, Recruiting, Assiut University | Trial completion date: Aug 2024 --> Mar 2025 | Trial primary completion date: Jun 2024 --> Dec 2024
Trial completion date • Trial primary completion date
5ms
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief Report. (PubMed, JTO Clin Res Rep)
TROP2 expression in thymic carcinoma was confirmed by both RNA-seq and IHC, with high expression observed in IHC for intensity (76.9%) and proportion. TROP2 could be a potential target in thymic carcinoma.
Journal
|
TACSTD2 (Tumor Associated Calcium Signal Transducer 2)
5ms
Squamous Cell Carcinoma Arising in YAP1::MAML2 Fusion-Associated Metaplastic Thymoma: A Case Report. (PubMed, Int J Surg Pathol)
In recent years, both conventional metaplastic thymomas and this subset showing malignant transformation have been associated with recurrent YAP1::MAML2 fusions. We report a metaplastic thymoma showing transformation to squamous cell carcinoma, that to our knowledge is the fourth reported in the literature with transition to overtly malignant features and the first showing pure carcinomatous transformation, and in which YAP1::MAML2 fusion was demonstrated via next generation sequencing.
Journal
|
YAP1 (Yes associated protein 1) • MAML2 (Mastermind Like Transcriptional Coactivator 2)
5ms
Aberrant expression of LGALS3BP drives an unfavorable prognosis and more aggressive in HCC via regulating PI3K/AKT signaling. (PubMed, Tissue Cell)
Mechanically, upon LGALS3BP depletion, the tumor-suppressive function was dependent on inactivating Phosphatidylinositol 3-kinase (PI3K)/V-akt murine thymoma viral oncogene homolog (AKT) signaling pathway. Collectively, these findings suggest that LGALS3BP employs a pro-tumorigenic function in HCC and may be a promising HCC prognostic marker.
Journal
|
LGALS3 (Galectin 3) • LGALS3BP (Lectin galactoside-binding soluble 3-binding protein)
5ms
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy (clinicaltrials.gov)
P2, N=55, Recruiting, National Cancer Institute (NCI) | Trial completion date: Jun 2025 --> Jun 2026 | Trial primary completion date: Jun 2024 --> Jun 2025
Trial completion date • Trial primary completion date
|
PD-L1 (Programmed death ligand 1)
|
Bavencio (avelumab)
5ms
Severe Relapsing Autoimmune Encephalitis with GABAA Receptor, Titin, and AchR Antibodies in a Patient with Thymoma: A Case Report. (PubMed, Case Rep Neurol)
He presented multiple severe relapses despite complete thymoma resection, intravenous methylprednisolone with immunoglobulins or plasmapheresis, and mycophenolate mofetil. Second-line immunotherapy with rituximab was successful to alleviate symptoms and normalize the EEG and MRI after identification of anti-GABAA receptor antibodies on more comprehensive neural antibody testing for autoimmune encephalitis. This case demonstrates the complexity and importance of identifying pathogenic antibodies and selecting 2nd line treatment accordingly in patients with autoimmune encephalitis when multiple antibodies coexist. Despite tumor resection, aggressive immunotherapy may be needed to prevent further deterioration in anti-GABAA receptor encephalitis.
Journal
|
TTN (Titin)
|
Rituxan (rituximab) • methylprednisolone sodium succinate